France
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4,085.55 |
Jan. 14, 2025 | USD 6.44 | -3.56% |
|
France |
|
2 |
236.48 |
Jan. 14, 2025 | USD 1.74 | -2.29% |
|
France |
|
3 |
81.87 |
Jan. 14, 2025 | USD 6.25 | -0.54% |
|
France |
|
4 |
61.87 |
Jan. 14, 2025 | USD 6.91 | 0.46% |
|
France |
|
5 |
48.41 |
Jan. 14, 2025 | USD 8.53 | 3.61% |
|
France |
|
6 |
47.90 |
Jan. 14, 2025 | USD 4.25 | 1.59% |
|
France |
|
7 |
42.24 |
Jan. 14, 2025 | USD 1.53 | 0.60% |
|
France |
|
8 |
41.23 |
Jan. 14, 2025 | USD 1.42 | -0.83% |
|
France |
|
9 |
40.07 |
Jan. 14, 2025 | USD 6.08 | 1.81% |
|
France |
|
10 |
38.50 |
Jan. 14, 2025 | USD 16.86 | 0.98% |
|
France |
|
11 |
13.62 |
Jan. 14, 2025 | USD 1.95 | -2.23% |
|
France |
|
12 |
12.57 |
Jan. 14, 2025 | USD 1.82 | 1.18% |
|
France |
|
13 |
11.33 |
Jan. 14, 2025 | USD 2.29 | 4.37% |
|
France |
|
14 |
8.72 |
Jan. 14, 2025 | USD 1.29 | -1.75% |
|
France |
|
15 |
7.32 |
Jan. 14, 2025 | USD 12.26 | 1.46% |
|
France |
|
16 |
6.61 |
Jan. 14, 2025 | USD 208.18 | -0.28% |
|
France |
|
17 |
5.55 |
Jan. 14, 2025 | USD 3.40 | -0.30% |
|
France |
|
18 |
4.55 |
Jan. 14, 2025 | USD 1.50 | -9.33% |
|
France |
|
19 |
4.38 |
Jan. 14, 2025 | USD 3.05 | 0.95% |
|
France |
|
20 |
3.47 |
Jan. 14, 2025 | USD 0.68 | -1.49% |
|
France |
|
21 |
3.22 |
Jan. 14, 2025 | USD 110.89 | -1.59% |
|
France |
|
22 |
2.95 |
Jan. 14, 2025 | USD 2.16 | 6.70% |
|
France |
|
23 |
2.78 |
Jan. 14, 2025 | USD 122.64 | 0.35% |
|
France |
|
24 |
2.75 |
Jan. 14, 2025 | USD 1.88 | -0.49% |
|
France |
|
25 |
2.08 |
Jan. 13, 2025 | USD 20.08 K | 0.04% |
|
France |
|
26 |
1.82 |
Jan. 14, 2025 | USD 26.07 | 0.60% |
|
France |
|
27 |
1.66 |
Jan. 14, 2025 | USD 3.97 | 0.60% |
|
France |
|
28 |
0.25 |
Jan. 14, 2025 | USD 2.27 | 11.78% |
|
France |
|
29 |
0.16 |
Jan. 14, 2025 | USD 0.96 | -6.39% |
|
France |
The Biotechnology company in France with the highest Price to Sales Ratio (P/S) is Carbios SAS (Paris Stock Exchange: ALCRB.PA) at 4,085.55.
The Biotechnology company in France with the lowest Price to Sales Ratio (P/S) is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at 0.16.
The top 10 Biotechnology companies in France by Price to Sales Ratio (P/S) are Carbios SAS, Cellectis S.A., ABIVAX Société Anonyme, OSE Immunotherapeutics SA, MaaT Pharma SA, Predilife S.A., Ikonisys S.A., Affluent Medical SA, Adocia SA and MedinCell S.A..
The bottom 10 Biotechnology companies in France by Price to Sales Ratio (P/S) are Neovacs S.A., Biosynex SA, genOway Société anonyme, Eurobio Scientific Société anonyme, Eurofins-Cerep SA, Innate Pharma S.A., Ipsen S.A., Aelis Farma SA, bioMérieux S.A. and Novacyt S.A..